Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
hVIVO Gelecekteki Büyüme
Future kriter kontrolleri 2/6
hVIVO's earnings are forecast to decline at 15.2% per annum while its annual revenue is expected to grow at 4.7% per year. EPS is expected to decline by 19.1% per annum. Return on equity is forecast to be 21.2% in 3 years.
Anahtar bilgiler
-15.2%
Kazanç büyüme oranı
-19.1%
EPS büyüme oranı
Life Sciences kazanç büyümesi | 25.9% |
Gelir büyüme oranı | 4.7% |
Gelecekteki özkaynak getirisi | 21.2% |
Analist kapsamı | Good |
Son güncelleme | 30 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
hVIVO plc's (LON:HVO) Intrinsic Value Is Potentially 28% Above Its Share Price
Jan 26Improved Revenues Required Before hVIVO plc (LON:HVO) Stock's 26% Jump Looks Justified
Jan 03At UK£0.20, Is hVIVO plc (LON:HVO) Worth Looking At Closely?
Nov 30A Piece Of The Puzzle Missing From hVIVO plc's (LON:HVO) Share Price
Jun 14A Look At The Intrinsic Value Of hVIVO plc (LON:HVO)
Feb 01Should You Investigate hVIVO plc (LON:HVO) At UK£0.11?
Dec 20Is There An Opportunity With Open Orphan Plc's (LON:ORPH) 41% Undervaluation?
Sep 13Are Investors Undervaluing Open Orphan plc (LON:ORPH) By 44%?
Jun 02Introducing Open Orphan (LON:ORPH), The Stock That Soared 388% In The Last Year
Feb 15How Much Of Open Orphan plc (LON:ORPH) Do Insiders Own?
Dec 23Calculating The Fair Value Of Open Orphan plc (LON:ORPH)
Nov 18Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 74 | 11 | 14 | 15 | 4 |
12/31/2025 | 68 | 10 | 15 | 17 | 7 |
12/31/2024 | 62 | 9 | 10 | 14 | 7 |
6/30/2024 | 67 | 17 | 7 | 13 | N/A |
3/31/2024 | 63 | 17 | 9 | 15 | N/A |
12/31/2023 | 59 | 16 | 12 | 17 | N/A |
9/30/2023 | 60 | 9 | 16 | 19 | N/A |
6/30/2023 | 60 | 3 | 19 | 20 | N/A |
3/31/2023 | 56 | 1 | 17 | 18 | N/A |
12/31/2022 | 51 | -1 | 15 | 16 | N/A |
9/30/2022 | 43 | -1 | 10 | 11 | N/A |
6/30/2022 | 35 | -1 | 5 | 7 | N/A |
3/31/2022 | 37 | -1 | 3 | 4 | N/A |
12/31/2021 | 39 | 0 | 0 | 1 | N/A |
9/30/2021 | 39 | -2 | 1 | 2 | N/A |
6/30/2021 | 39 | -3 | 2 | 4 | N/A |
3/31/2021 | 30 | -7 | 3 | 4 | N/A |
12/31/2020 | 22 | -11 | 3 | 4 | N/A |
9/30/2020 | 16 | -11 | -1 | -1 | N/A |
6/30/2020 | 10 | -11 | -6 | -5 | N/A |
3/31/2020 | 7 | -8 | -4 | -4 | N/A |
12/31/2019 | 3 | -6 | -3 | -3 | N/A |
6/30/2019 | N/A | -2 | -1 | -1 | N/A |
3/31/2019 | N/A | -1 | -1 | -1 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: HVO's earnings are forecast to decline over the next 3 years (-15.2% per year).
Kazançlar ve Piyasa: HVO's earnings are forecast to decline over the next 3 years (-15.2% per year).
Yüksek Büyüme Kazançları: HVO's earnings are forecast to decline over the next 3 years.
Gelir ve Pazar: HVO's revenue (4.7% per year) is forecast to grow faster than the UK market (3.8% per year).
Yüksek Büyüme Geliri: HVO's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: HVO's Return on Equity is forecast to be high in 3 years time (21.2%)